CLINICAL_TRIALS
research
· 2025-07-31
Clinical Trial Update: EyeConic: Qualification for Cone-Optogenetics
Summary
EyeConic cone-optogenetics is in the recruitment phase for a study addressing retinal dystrophies. The sponsor is the Institute of Molecular and Clinical Ophtha…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute of Molecular and Clinical Ophthalmology Basel | Conditions: Retinal Dystrophies | Status: RECRUITING